A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients

Article Abstract:

Three nucleoside reverse transcriptase inhibitors appear to be better than two, according to a study of 106 HIV patients who took zidovudine and lamivudine or zidovudine, lamivudine, and didanosine.

Evaluation, HIV infection, HIV infections, Drug therapy, Combination, Combination drug therapy

---

Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infection

Article Abstract:

The long-term immunologic and virologic efficacy of the dual- and triple-nucleoside therapy for HIV infection was compared in a retrospective analysis of two randomized clinical trials in antiretroviral-naive patients in Thailand. The triple-nucleoside therapy proved more effective in inducing a sustained virologic response than the dual-nucleoside therapy as stated.

Biological Product (except Diagnostic) Manufacturing, HEALTH SERVICES, All Other Miscellaneous Ambulatory Health Care Services, Nucleic Acid Derivatives, Disease Testing Programs, HIV (Viruses), HIV, Dosage and administration, Drug evaluation, Nucleosides

---

The TREAT Asia HIV observational database: Baseline and retrospective data

Article Abstract:

Data collected on HIV-infected patients from the Asia-Pacific region were centrally aggregated for analyses, with the first baseline and retrospective data transferred in September 2003. By the end of May 2004, 1887 patients had been recruited to the TREAT Asia HIV Observational Database.

Asia, Health aspects, Usage, HIV patients, AIDS (Disease), AIDS research, Highly active antiretroviral therapy

Similar abstracts:

• Abstracts: Open-label phase II trial of amprenavir, abacavir, and fixed-dose zidovudine/lamivudine in newly and chronically HIV-1-infected patients
• Abstracts: Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogenn activator in acute myocardial infarction
• Abstracts: Zidovudine genotypic resistance in HIV-1-infected newborns in the French Perinatal Cohort. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.